XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
IPO
Common Stock
Common Stock
IPO
Additional Paid-in Capital
Additional Paid-in Capital
IPO
Accumulated Other Comprehensive Loss
Accumulated Deficit
Convertible Preferred Stock
Balance at Dec. 31, 2019 $ (65,357)       $ (43,172)     $ (22,185)  
Temporary equity, balance, Shares at Dec. 31, 2019                 37,267
Temporary equity, balance at Dec. 31, 2019                 $ 134,720
Balance, Shares at Dec. 31, 2019     2,989            
Issuance of common stock upon exercise of stock options, net of repurchases 16       16        
Issuance of common stock upon exercise of stock options, net of repurchases, Shares     41            
Vesting of early exercise options 14       14        
Issuance of convertible preferred stock, net of issuance costs                 $ 2,200
Issuance of convertible preferred stock, net of issuance costs, Shares                 538
Stock-based compensation 449       449        
Net loss (6,085)             (6,085)  
Balance at Mar. 31, 2020 (70,963)       (42,693)     (28,270)  
Temporary equity, balance, Shares at Mar. 31, 2020                 37,805
Temporary equity, balance at Mar. 31, 2020                 $ 136,920
Balance, Shares at Mar. 31, 2020     3,030            
Balance at Dec. 31, 2019 (65,357)       (43,172)     (22,185)  
Temporary equity, balance, Shares at Dec. 31, 2019                 37,267
Temporary equity, balance at Dec. 31, 2019                 $ 134,720
Balance, Shares at Dec. 31, 2019     2,989            
Reclassification of warrant liability to equity due to adjustment from preferred stock warrant to common stock warrant upon completion of initial public offering 120                
Net loss (16,641)                
Balance at Jun. 30, 2020 330,296   $ 4   369,118     (38,826)  
Balance, Shares at Jun. 30, 2020     37,527            
Balance at Mar. 31, 2020 (70,963)       (42,693)     (28,270)  
Temporary equity, balance, Shares at Mar. 31, 2020                 37,805
Temporary equity, balance at Mar. 31, 2020                 $ 136,920
Balance, Shares at Mar. 31, 2020     3,030            
Vesting of early exercise options 34       34        
Issuance of stock, net of issuance costs, Value   $ 274,054   $ 2   $ 274,052      
Issuance of stock, net of issuance costs, Shares       16,560          
Conversion of convertible preferred stock into common stock upon completion of initial public offering 136,920   $ 2   136,918       $ (136,920)
Conversion of convertible preferred stock into common stock upon completion of initial public offering, Shares     17,921           (37,805)
Reclassification of warrant liability to equity due to adjustment from preferred stock warrant to common stock warrant upon completion of initial public offering 120       120        
Cashless exercise of common stock warrants, Shares     16            
Stock-based compensation 687       687        
Net loss (10,556)             (10,556)  
Balance at Jun. 30, 2020 330,296   $ 4   369,118     (38,826)  
Balance, Shares at Jun. 30, 2020     37,527            
Balance at Dec. 31, 2020 306,223   $ 4   372,764   $ (5) (66,540)  
Balance, Shares at Dec. 31, 2020     37,569            
Issuance of common stock upon exercise of stock options 24       24        
Issuance of common stock upon exercise of stock options, Shares     31            
Vesting of early exercise options 10       10        
Stock-based compensation 3,701       3,701        
Net loss (23,844)             (23,844)  
Other comprehensive gain 2           2    
Balance at Mar. 31, 2021 286,116   $ 4   376,499   (3) (90,384)  
Balance, Shares at Mar. 31, 2021     37,600            
Balance at Dec. 31, 2020 $ 306,223   $ 4   372,764   (5) (66,540)  
Balance, Shares at Dec. 31, 2020     37,569            
Issuance of common stock upon exercise of stock options, Shares 82                
Reclassification of warrant liability to equity due to adjustment from preferred stock warrant to common stock warrant upon completion of initial public offering $ 0                
Net loss (50,197)                
Balance at Jun. 30, 2021 264,480   $ 4   381,213     (116,737)  
Balance, Shares at Jun. 30, 2021     37,665            
Balance at Mar. 31, 2021 286,116   $ 4   376,499   (3) (90,384)  
Balance, Shares at Mar. 31, 2021     37,600            
Issuance of common stock upon exercise of stock options 98       98        
Issuance of common stock upon exercise of stock options, Shares     51            
Issuance of common stock under employee stock purchase plan 318   $ 14   318        
Vesting of early exercise options 9       9        
Stock-based compensation 4,289       4,289        
Net loss (26,353)             (26,353)  
Other comprehensive gain 3           $ 3    
Balance at Jun. 30, 2021 $ 264,480   $ 4   $ 381,213     $ (116,737)  
Balance, Shares at Jun. 30, 2021     37,665